Key result
Plasma FGF-5 accurately discriminates familial hypercholesterolemia from controls with an AUC of >0.99.
Why the study?
Does plasma FGF-5 measurement distinguish individuals with familial hypercholesterolaemia from hypercholesterolaemic individuals and controls?
Observational
Does plasma FGF-5 measurement distinguish individuals with familial hypercholesterolaemia from hypercholesterolaemic individuals and controls?
Answers are grounded in this paper and cite their sources.
FGF-5 is a novel biomarker that can accurately discriminate individuals with familial hypercholesterolaemia from those with general hypercholesterolaemia, even when matched for LDL-C levels.
BACKGROUND AND AIMS: Identification of individuals affected by familial hypercholesterolaemia (FH) is suboptimal when genetic tests are unavailable. Relying only on low-density lipoprotein cholesterol (LDL-C) is challenging as it may not allow distinguishing individuals with FH from hypercholesterolaemic (HC) individuals from the general population. The aim of this study was to determine whether biomarkers associated with cardiovascular disease and/or inflammation identify FH individuals and distinguish them from HC individuals. METHODS: A panel of 264 proteins in plasma was measured and machine learning was used to search for those that can distinguish FH individuals, either genetically proven (genFH) or clinically diagnosed (clinFH) from HC and control individuals. RESULTS: Both genFH and clinFH had elevated plasma levels of fibroblast growth factor 5 (FGF-5) compared with controls (mean area under the curve [AUC] > .990 for both, P < .001) or HC individuals (mean AUC >.990, P < .001), even after matching for LDL-C levels. An immunoenzymatic assay confirmed that FGF-5 was elevated in genFH and clinFH in all cohorts analysed. CONCLUSIONS: This analysis suggests that FGF-5 could be a biomarker to discriminate individuals living with FH from HC individuals.
No takes yet. Share an insight, caveat, or question.
Baragetti et al. (2025) conducted an observational in Familial hypercholesterolaemia. Fibroblast growth factor 5 (FGF-5) vs. Hypercholesterolaemic individuals and controls was evaluated on Discrimination of familial hypercholesterolaemia from hypercholesterolaemic individuals and controls (mean AUC >0.990, p=<0.001). Plasma fibroblast growth factor 5 (FGF-5) accurately discriminated individuals with familial hypercholesterolaemia from hypercholesterolaemic individuals and controls.
Synapse has enriched 10 related papers. Consider them for comparative context: